Evidence map›Paper›PMID 28259724›Full record

ReviewInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2017

Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions.

Seif S Al-Abri, Idris Al Abaidani, Mehdi Fazlalipour, Ehsan Mostafavi, Hakan Leblebicioglu, Natalia Pshenichnaya, Ziad A Memish, Roger Hewson, Eskild Petersen, Peter Mala and 4 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Seif S Al-AbriMinistry of Health, Oman.
Idris Al AbaidaniDepartment of Communicable Diseases, Ministry of Health, Oman.
Mehdi FazlalipourDepartment of Arbovirus and Viral Hemorrhagic Fever, Pasteur Institute of Iran, Tehran, Iran.
Ehsan MostafaviResearch Centre for Emerging and Re-emerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
Hakan LeblebiciogluDepartment of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University, Samsun, Turkey.
Natalia PshenichnayaHead of Infectious Diseases Department, Infectious Disease Department, Rostov State Medical University, Moscow, Russia.
Ziad A MemishHubert Department of Global Health, School of Public Health, Emory University, Atlanta, USA.
Roger HewsonArboviruses and VHFs, WHO Collaborating Centre (Special Pathogens), National Infection Service Public Health England, Porton Down, Salisbury, UK.
Eskild PetersenInfectious Diseases, The Royal Hospital, Muscat, Oman.
Peter MalaInfectious Hazards Management, World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt.
Tran Minh Nhu NguyenInfectious Hazards Management, World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt.
Mamunur Rahman MalikInfectious Hazards Management, World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt. Electronic address: malikm@who.int.
Pierre FormentyInfectious Hazards Management, World Health Organization, Geneva, Switzerland.
Rosanna JeffriesInfectious Hazards Management, World Health Organization, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is the most widespread, tick-borne viral disease affecting humans. The disease is endemic in many regions, such as Africa, Asia, Eastern and Southern Europe, and Central Asia. Recently, the incidence of CCHF has increased rapidly in the countries of the World Health Organization Eastern Mediterranean Region (WHO EMR), with sporadic human cases and outbreaks of CCHF being reported from a number of countries in the region. Despite the rapidly growing incidence of the disease, there are currently no accurate data on the burden of the disease in the region due to the different surveillance systems used for CCHF in these countries. In an effort to increase our understanding of the epidemiology and risk factors for the transmission of the CCHF virus (CCHFV; a Nairovirus of the family Bunyaviridae) in the WHO EMR, and to identify the current knowledge gaps that are hindering effective control interventions, a sub-regional meeting was organized in Muscat, Oman, from December 7 to 9, 2015. This article summarizes the current knowledge of the disease in the region, identifies the knowledge gaps that present challenges for the prevention and control of CCHFV, and details a strategic framework for research and development activities that would be necessary to curb the ongoing and new threats posed by CCHFV.

Indexed as

Global HealthForecastingHemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoHumansIncidenceMediterranean RegionRisk FactorsWorld Health OrganizationCCHFCCHF virusEastern Mediterranean RegionIxodid ticksKnowledge gaps

Identifiers

PMID28259724
PMCPMC7110796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.